Vanhoof; Greta Constantia Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vanhoof; Greta Constantia Peter.The latest application filed is for "combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-a]]quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological of metabolic disorders".

Company Profile

2.8.9

Vanhoof; Greta Constantia Peter - Beerse N/A BE
Vanhoof; Greta Constantia Peter - Zoersel N/A BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives Grant 10,604,523 - Andres-Gil , et al.	2020-03-31
Combinations Comprising Pde 2 Inhibitors Such As 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-a]]quinoxaline Compounds And Pde 10 Inhibitors For Use In The Treatment Of Neurological Of Metabolic Disorders App 20150366873 - Megens; Antonius Adrianus Hendrikus Petrus ; et al.	2015-12-24
Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases Grant 8,859,543 - Bartolome-Nebreda , et al. October 14, 2	2014-10-14
1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES App 20140147386 - Andres-Gil; Jose Ignacio ; et al.	2014-05-29
Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors Grant 8,716,282 - Pastor-Fernandez , et al. May 6, 2	2014-05-06
IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES App 20120329792 - Bartolome-Nebreda; Jose Manuel ; et al.	2012-12-27
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS App 20120220581 - Pastor-Fernandez; Joaquin ; et al.	2012-08-30
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS App 20110269752 - Pastor-Fernandez; Joaquin ; et al.	2011-11-03
Adamantyl acetamides as 11-.beta. hydroxysteroid dehydrogenase inhibitors Grant 7,968,601 - Linders , et al. June 28, 2	2011-06-28
Adamantyl Acetamides As 11-beta Hydroxysteroid Dehydrogenase Inhibitors App 20080096869 - Linders; Joannes Theodorus Maria ; et al.	2008-04-24
Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors Grant 7,332,524 - Linders , et al. February 19, 2	2008-02-19
Benzisoxazoles App 20070197610 - Kennis; Ludo Edmond Josephine ; et al.	2007-08-23
Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors App 20060079506 - Linders; Joannes Theodorus Maria ; et al.	2006-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.